Top Story

Safety concerns common reason for hepatitis B vaccine refusal

October 24, 2014

SAN DIEGO — Safety and uncertainty involving the risk for hepatitis B are reasons for barriers to vaccine uptake, according to recent study findings presented at the 2014 AAP National Conference and Exhibition.

“Universal hepatitis B vaccination is recommended beginning in the immediate post-natal period,” Bronwyn Baz, MD, of Oregon Health and Science University, wrote in the abstract. “Refusal remains a barrier to universal inoculation. Studying the qualities of groups refusing vaccines, including hepatitis B, may be helpful in identifying strategies for uptake improvement. We assessed uptake of the newborn hepatitis vaccine … with the goal of assessing reasons for refusal and identifying potential interventions.”

FDA News

FDA to review pediatric hexavalent vaccine

October 21, 2014
The FDA has accepted for review a Biologics License Application filed by Merck and Sanofi Pasteur for a pediatric hexavalent combination vaccine containing DTaP…
figure

NIH awards seven research grants for vaccine adjuvants

October 18, 2014
The National Institute of Allergy and Infectious Diseases, a division of the NIH, has awarded seven research grants to separate institutions to explore and develop new…

$5.8 million contract awarded for development of third Ebola vaccine

October 17, 2014
The US Department of Health and Human Services announced a $5.8 million contract toward the development of a third Ebola vaccine, according to a press release.The…
5 Questions

A Conversation with Samuel L. Katz, MD

Pediatric Annals, August 2012, Volume 41 Issue 8
More »
CME
figure

Immunization An Update

Keck School of Medicine of USC and Pediatric Annals

In the current environment of increasing vaccine refusal, the pediatrician has a powerful role to play as a trusted…
More »

Filter By:

Meeting News Coverage

Safety concerns common reason for hepatitis B vaccine refusal

October 24, 2014
SAN DIEGO — Safety and uncertainty involving the risk for hepatitis B are reasons for barriers to vaccine uptake, according to recent study…
FDA News

FDA to review pediatric hexavalent vaccine

October 21, 2014
The FDA has accepted for review a Biologics License Application filed by Merck and Sanofi Pasteur for a pediatric hexavalent combination vaccine…
figure

NIH awards seven research grants for vaccine adjuvants

October 18, 2014
The National Institute of Allergy and Infectious Diseases, a division of the NIH, has awarded seven research grants to separate institutions to…

$5.8 million contract awarded for development of third Ebola vaccine

October 17, 2014
The US Department of Health and Human Services announced a $5.8 million contract toward the development of a third Ebola vaccine, according to a…
In the Journals

Vaccination coverage rates high among US kindergarteners

October 16, 2014
Routine vaccination coverage among children in kindergarten was at or near the 95% national Healthy People 2020 target for DTaP…
figure In the Journals

Current tobacco use associated with oral HPV-16 infection

October 14, 2014
Researchers identified a significant relationship between oral HPV-16 infection and behavioral and objective biomarkers of current tobacco use…
In the Journals

More evidence may be needed to confirm long-term HPV vaccine efficacy

October 7, 2014
Study data from long-term observation did not indicate any loss of antiviral protection after vaccination against HPV types 16 and 18, but stronger…
In the Journals

Tdap vaccination rate low among pregnant women on Medicaid

October 2, 2014
Only 14.3% of women on Medicaid in Michigan received the Tdap vaccine during their pregnancies from November 2011 to February 2013, according to…
figure In the Journals

Effective implementation of nine-valent HPV vaccination could prevent majority of cervical cancers

October 1, 2014
Most cervical precancers appear to be caused by one of nine types of HPV, according to study results.The findings suggest an investigational…
Editorial

Meningococcal disease: An update on meningococcal B vaccination

Infectious Diseases in Children, October 2014
Steven B. Black, MD
Meningococcal disease may be relatively rare, but it remains a serious public health concern because of the high risk for mortality and severe…
More Headlines »